Company news

IRLAB Therapeutics AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IRLAB Appoints Janne Backman as New Chairman of the Board

September 24, 2026

Report from the Extraordinary General Meeting of IRLAB Therapeutics AB

June 5, 2026

IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)

January 19, 2026

IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease

December 23, 2025

The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam

December 11, 2025

IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer

October 9, 2025

IRLAB Progresses Fully Funded IRL757 Study in Parkinson's Disease in Partnership with MSRD

October 2, 2025

IRLAB Is Granted a Patent Strengthening the Market Exclusivity of The Drug Candidate Mesdopetam in China

September 4, 2025

IRLAB Appoints Roy Jonebrant as Interim CFO

August 21, 2025

IRLAB Reports Positive Results from the Second Part of a Phase I Study with IRL757

May 28, 2025

IRLAB is Granted a Patent Expanding the Patent Protection for the Drug Candidate Mesdopetam in the US

May 13, 2025

Calls

The 5 newest of 8 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.